See also this year's filing and all EDGAR filings for this company.
PDF Report 0001012477_2018_Avadel_Pharmaceuticals_PLC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001012477, Avadel Pharmaceuticals PLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 123,975,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 110,780,000 |
| 2 | PropertyPlantAndEquipmentNet | 3,001,000 |
| 3 | remainder_Assets | 15,521,000 |
| 4 | LiabilitiesCurrent | 86,539,000 |
| 5 | LiabilitiesNoncurrent | 7,240,000 |
| 6 | remainder_Liabilities | 73,918,000 |
| 7 | CostOfGoodsAndServicesSold | 16,301,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 58,860,000 |
| 9 | ResearchAndDevelopmentExpense | 33,418,000 |
| 10 | remainder_Expenses | 602,000 |
| 11 | remainder_Revenues | 173,245,000 |
| 12 | remainder_NetIncome | 4,207,000 |
| 13 | remainder_ComprehensiveNetIncome | 299,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 253,277,000 |
| 1 | Liabilities | 167,697,000 |
| 2 | Expenses | 109,181,000 |
| 3 | Revenues | 173,245,000 |
| 4 | StockholdersEquity | 85,580,000 |
| 5 | NetIncome | 68,271,000 |
| 6 | ComprehensiveNetIncome | 68,420,500 |
| 7 | BaseVar | 353,953,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.21 |
| 9 | EconomicCapitalRatio | 2.47 |
Edgar->Model Mapping
Feature Distribution
Change over Time
